Trial Profile
A Prospective Multicenter Randomized Controlled Open-label Trial of Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary) ; Ethiodized oil; Pirarubicin
- Indications Liver cancer
- Focus Therapeutic Use
- 10 Nov 2016 New trial record